Bernard Roubert
Overview
Explore the profile of Bernard Roubert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pennell D, Porter J, Cappellini M, Chan L, El-Beshlawy A, Aydinok Y, et al.
Haematologica
. 2010 Nov;
96(1):48-54.
PMID: 21071497
Background: The efficacy of cardiac iron chelation in transfusion-dependent patients has been demonstrated in one-year prospective trials. Since normalization of cardiac T2* takes several years, the efficacy and safety of...
22.
Lee J, Yoon S, Shen Z, Ganser A, Hsu H, Habr D, et al.
Blood
. 2010 Jun;
116(14):2448-54.
PMID: 20566896
The prospective 1-year Evaluation of Patients' Iron Chelation with Exjade (EPIC) study enrolled a large cohort of 116 patients with aplastic anemia; the present analyses evaluated the efficacy and safety...
23.
Gattermann N, Finelli C, Porta M, Fenaux P, Ganser A, Guerci-Bresler A, et al.
Leuk Res
. 2010 May;
34(9):1143-50.
PMID: 20451251
The prospective 1-year EPIC study enrolled 341 patients with myelodysplastic syndromes (MDS); although baseline iron burden was >2500ng/mL, approximately 50% were chelation-naïve. Overall median serum ferritin decreased significantly at 1...
24.
Pennell D, Porter J, Cappellini M, El-Beshlawy A, Chan L, Aydinok Y, et al.
Blood
. 2009 Dec;
115(12):2364-71.
PMID: 19996412
Cardiac iron overload causes most deaths in beta-thalassemia major. The efficacy of deferasirox in reducing or preventing cardiac iron overload was assessed in 192 patients with beta-thalassemia in a 1-year...
25.
Cappellini M, Porter J, El-Beshlawy A, Li C, Seymour J, Elalfy M, et al.
Haematologica
. 2009 Dec;
95(4):557-66.
PMID: 19951979
Unlabelled: Background Following a clinical evaluation of deferasirox (Exjade) it was concluded that, in addition to baseline body iron burden, ongoing transfusional iron intake should be considered when selecting doses....